| Mrs Mary Ellen Cox Bandy, RPH | |
|
10150 Brook Rd, Glen Allen, VA 23059-6514 | |
| (804) 261-1760 | |
| Not Available |
| Full Name | Mrs Mary Ellen Cox Bandy |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10150 Brook Rd, Glen Allen, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215066527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202007166 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mary Ellen Cox Bandy, RPH 8027 Ellerson Wood Dr, Mechanicsville, VA 23111-5951 Ph: (804) 730-8435 | Mrs Mary Ellen Cox Bandy, RPH 10150 Brook Rd, Glen Allen, VA 23059-6514 Ph: (804) 261-1760 |
News Archive
The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or colorectal cancer with a high enough degree of reliability. These CTCs are the cause of metastases in cancer patients. If they can be effectively characterized, it is possible to arrive at a prognosis and to determine the most effective course of treatment.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company support the American Diabetes Association call for an independent review of the safety data of incretin-based therapies.
Researchers have found that the budding yeast (Saccharomyces cerevisiae) is an acceptable model system to study KP1019, an anti-cancer drug that uses ruthenium, a rare metal, a new study found. Researchers had previously been interested in studying KP1019 because it is believed to cause cancer cell death and is not known to have negative secondary side effects for healthy tissues.
Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapy for cancer, announced the presentation today of new preclinical data on the development of a miRNA-based therapeutic candidate for primary liver cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco, CA.
› Verified 8 days ago
Mrs. Kelley Smith Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9801 Brook Rd, Glen Allen, VA 23059 Phone: 804-264-9587 | |
Mr. Marvin Warren Bridgers Iii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 Cox Rd, Ste 100, Glen Allen, VA 23060 Phone: 804-822-4383 Fax: 804-965-0987 | |
Weston Alberto Williams Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11613 Autumnwood Way, Glen Allen, VA 23059 Phone: 804-364-2405 | |
Dr. Kimberly Dawn Sturgill, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10250 Staples Mill Rd, Glen Allen, VA 23060 Phone: 804-755-6207 | |
Mr. Moboluwaji Akinfolajimi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9414 Broad Meadows Rd, Glen Allen, VA 23060 Phone: 804-935-0999 Fax: 804-935-0999 | |
Ms. Rebecca Dell Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11290 W Broad St, Glen Allen, VA 23060 Phone: 804-360-8912 Fax: 804-360-8912 | |
Dr. Sarah German Sanders, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10100 Brook Rd, Glen Allen, VA 23059 Phone: 804-262-4603 Fax: 804-262-4603 |